| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $40.3M | +14.5% |
| Cost of Revenue | $8.8M | +20.6% |
| Gross Profit | $31.6M | +12.9% |
| R&D Expense | $4.6M | -9.6% |
| SG&A Expense | $15.2M | +12.2% |
| Operating Income | -$1.8M | +46.0% |
| Income Tax | $0 | — |
| Net Income | -$3.1M | +27.7% |
| EPS (Basic) | -$0.25 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.3M | -6.4% |
| Accounts Receivable | $6.6M | +10.5% |
| Current Assets | $12.6M | +4.1% |
| Total Assets | $32.2M | +8.3% |
| Current Liabilities | $14.4M | +24.6% |
| Long-term Debt | $13.4M | +96.5% |
| Total Liabilities | $27.4M | +34.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.8M | +74.0% |
| Capital Expenditures | $54K | -57.8% |
| Investing Cash Flow | -$4.2M | +41.8% |
| Financing Cash Flow | -$920K | -202.4% |
| Free Cash Flow | $4.7M | +80.5% |
| +30.6% |
| EPS (Diluted) | -$0.25 | +30.6% |
| Stockholders' Equity |
| $4.8M |
| -49.1% |